These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24124216)

  • 1. Q&A: Geoffrey Shapiro on phase I drug trials. Spoke with Suzanne Rose.
    Shapiro G
    Cancer Discov; 2013 Oct; 3(10):1089. PubMed ID: 24124216
    [No Abstract]   [Full Text] [Related]  

  • 2. Bypassing phase 1 trials in the cancer drug development paradigm: generally unwise and potentially dangerous.
    Markman M
    Cancer; 2010 Nov; 116(22):5116-8. PubMed ID: 20665504
    [No Abstract]   [Full Text] [Related]  

  • 3. Reanalysis of cancer drugs: old drugs, new tricks.
    Vande Woude GF; Kelloff GJ; Ruddon RW; Koo HM; Sigman CC; Barrett JC; Day RW; Dicker AP; Kerbel RS; Parkinson DR; Slichenmyer WJ
    Clin Cancer Res; 2004 Jun; 10(11):3897-907. PubMed ID: 15173099
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current status and issues in clinical trials of anticancer agents].
    Kojima H
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():295-301. PubMed ID: 7986107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle theories slowly turn into practice.
    Bender E
    Cancer Discov; 2011 Sep; 1(4):280. PubMed ID: 22586600
    [No Abstract]   [Full Text] [Related]  

  • 6. Disrupting cancer cells' biocircuits with interactome-based drugs: is 'clinical' innovation realistic?
    Roukos DH
    Expert Rev Proteomics; 2012 Aug; 9(4):349-53. PubMed ID: 22967071
    [No Abstract]   [Full Text] [Related]  

  • 7. Review: new biological insights in early clinical studies.
    Maur M; Sessa C
    Hematol Oncol; 2007 Jun; 25(2):53-7. PubMed ID: 17351979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I studies of chemotherapeutic agents in cancer patients: a review of the designs.
    Potter DM
    J Biopharm Stat; 2006; 16(5):579-604. PubMed ID: 17037260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial design in metastatic breast cancer: a commentary.
    Levine M
    Can J Oncol; 1995 Dec; 5 Suppl 1():40-2. PubMed ID: 8853523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalaria drug offers antitumor strategies.
    Hede K
    J Natl Cancer Inst; 2011 Oct; 103(20):1490-1. PubMed ID: 21972227
    [No Abstract]   [Full Text] [Related]  

  • 11. "Therapeutic intent" in phase 1 oncology trials: a justifiable objective.
    Markman M
    Arch Intern Med; 2006 Jul; 166(14):1446-8. PubMed ID: 16864753
    [No Abstract]   [Full Text] [Related]  

  • 12. [Successes in late solid tumors. New therapy offer].
    Arnheim K
    MMW Fortschr Med; 2004 Nov; 146(47):71. PubMed ID: 15624667
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer trial assesses clinical benefit of gene-targeted treatment.
    Katsnelson A
    Nat Biotechnol; 2014 Apr; 32(4):306. PubMed ID: 24714466
    [No Abstract]   [Full Text] [Related]  

  • 14. Preclinical and clinical experience of antisense therapy for solid tumors.
    Webb MS; Zon G
    Curr Opin Mol Ther; 1999 Aug; 1(4):458-63. PubMed ID: 11713760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 1 trials in cancer patients: a review of the toxicity, antitumor and hematopoietic effects.
    Veltri S; Smith JW
    Stem Cells; 1996 Mar; 14(2):164-76. PubMed ID: 8991536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herceptin (trastuzumab): adjuvant and neoadjuvant trials.
    Yaal-Hahoshen N; Safra T
    Isr Med Assoc J; 2006 Jun; 8(6):416-21. PubMed ID: 16833172
    [No Abstract]   [Full Text] [Related]  

  • 17. Is response rate relevant to the phase II trial design of targeted agents?
    Dowlati A; Fu P
    J Clin Oncol; 2008 Mar; 26(8):1204-5. PubMed ID: 18285601
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical development of targeted moledular cancer drugs].
    Zwierzina H; Borner M
    Onkologie; 2005 Oct; 28 Suppl 4():35-9. PubMed ID: 16205104
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer chemotherapy.
    Secchi GC
    Ann Ital Med Int; 1990; 5(3 Pt 3):288-95. PubMed ID: 2081089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials referral resource. Clinical trials using edatrexate.
    Cheson BD; Sorenson JM; Phillips PH
    Oncology (Williston Park); 1993 Jul; 7(7):33-4. PubMed ID: 8347459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.